Use of 1-(2-ethoxy-2-(3′-pyridyl)ethyl)-4-(2′-methoxy-phenyl)piperazine, or its enantiomers or pharmaceutically acceptable addition salts thereof, for the preparation of pharmaceutical compositions useful for the treatment of lower urinary tract disfunctions and benign prostatic hypertrophy.
1-(2-乙氧基-2-(3′-
吡啶基)乙基)-4-(2′-
甲氧基苯基)
哌嗪或其对映体或药学上可接受的加成盐用于制备治疗下尿路功能障碍和良性前列腺肥大的药物组合物。